These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 110689)

  • 41. Detection of antibodies to Pseudomonas aeruginosa alginate extracellular polysaccharide in animals and cystic fibrosis patients by enzyme-linked immunosorbent assay.
    Bryan LE; Kureishi A; Rabin HR
    J Clin Microbiol; 1983 Aug; 18(2):276-82. PubMed ID: 6413528
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of culture conditions and immunization in experimental nutritionally variant streptococcal endocarditis.
    van de Rijn I
    Infect Immun; 1985 Dec; 50(3):641-6. PubMed ID: 4066025
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-PcrV antibody strategies against virulent Pseudomonas aeruginosa.
    Sawa T; Ito E; Nguyen VH; Haight M
    Hum Vaccin Immunother; 2014; 10(10):2843-52. PubMed ID: 25483637
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Lang AB; Schaad UB; Rüdeberg A; Wedgwood J; Que JU; Fürer E; Cryz SJ
    J Pediatr; 1995 Nov; 127(5):711-7. PubMed ID: 7472821
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of alginase on the natural history and antibiotic therapy of experimental endocarditis caused by mucoid Pseudomonas aeruginosa.
    Bayer AS; Park S; Ramos MC; Nast CC; Eftekhar F; Schiller NL
    Infect Immun; 1992 Oct; 60(10):3979-85. PubMed ID: 1398909
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunization with 3-oxododecanoyl-L-homoserine lactone-r-PcrV conjugate enhances survival of mice against lethal burn infections caused by Pseudomonas aeruginosa.
    Golpasha ID; Mousavi SF; Owlia P; Siadat SD; Irani S
    Bosn J Basic Med Sci; 2015 May; 15(2):15-24. PubMed ID: 26042508
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Experimental study of the dynamics of the formation of protective antibodies to the antigens of the slime of Pseudomonas aeruginosa].
    Iushkova NA; Stanislavskiĭ ES; Landsman NM
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Mar; (3):78-83. PubMed ID: 6405564
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Active immunization with lipopolysaccharide Pseudomonas antigen for chronic Pseudomonas bronchopneumonia in guinea pigs.
    Pennington JE; Hickey WF; Blackwood LL; Arnaut MA
    J Clin Invest; 1981 Nov; 68(5):1140-8. PubMed ID: 6795229
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Passive immunity against pseudomonas sepsis during granulocytopenia.
    Harvath L; Andersen BR; Amirault HJ
    Infect Immun; 1976 Nov; 14(5):1151-5. PubMed ID: 824205
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of an anti-adhesive vaccine for Pseudomonas aeruginosa targeting the C-terminal region of the pilin structural protein.
    Sheth HB; Glasier LM; Ellert NW; Cachia P; Kohn W; Lee KK; Paranchych W; Hodges RS; Irvin RT
    Biomed Pept Proteins Nucleic Acids; 1995; 1(3):141-8. PubMed ID: 9346845
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Experimental Streptococcus sanguis endocarditis: immune complexes and renal involvement.
    Thörig L; Daha MR; Eulderink F; Kooy-Bauer WC; Thompson J
    Clin Exp Immunol; 1980 Jun; 40(3):469-77. PubMed ID: 7418263
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Critical influence of timing of administration of granulocyte colony-stimulating factor on antibacterial effect in experimental endocarditis due to Pseudomonas aeruginosa.
    Vignes S; Fantin B; Elbim C; Walker F; Gougerot-Pocidalo MA; Carbon C
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2702-7. PubMed ID: 8593006
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intranasal Peptide-Based FpvA-KLH Conjugate Vaccine Protects Mice From
    Sen-Kilic E; Blackwood CB; Boehm DT; Witt WT; Malkowski AC; Bevere JR; Wong TY; Hall JM; Bradford SD; Varney ME; Damron FH; Barbier M
    Front Immunol; 2019; 10():2497. PubMed ID: 31708925
    [No Abstract]   [Full Text] [Related]  

  • 54. Immunization with FimA protects against Streptococcus parasanguis endocarditis in rats.
    Viscount HB; Munro CL; Burnette-Curley D; Peterson DL; Macrina FL
    Infect Immun; 1997 Mar; 65(3):994-1002. PubMed ID: 9038308
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of immunization on susceptibility to experimental Streptococcus mutans and Streptococcus sanguis endocarditis.
    Durack DT; Gilliland BC; Petersdorf RG
    Infect Immun; 1978 Oct; 22(1):52-6. PubMed ID: 730349
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Systemic and topical protection studies using Pseudomonas aeruginosa flagella in an ocular model of infection.
    Rudner XL; Hazlett LD; Berk RS
    Curr Eye Res; 1992 Aug; 11(8):727-38. PubMed ID: 1424719
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunization with the ferric iron-binding periplasmic protein HitA provides protection against Pseudomonas aeruginosa in the murine infection model.
    Elhosary MA; Bahey-El-Din M; AbdelBary A; El Guink N; Aboushleib HM
    Microb Pathog; 2019 Jun; 131():181-185. PubMed ID: 30978430
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protective immunization against chronic Pseudomonas aeruginosa pulmonary infection in rats.
    Klinger JD; Cash HA; Wood RE; Miler JJ
    Infect Immun; 1983 Mar; 39(3):1377-84. PubMed ID: 6404823
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of beta-lactam resistance and increased quinolone MICs during therapy of experimental Pseudomonas aeruginosa endocarditis.
    Bayer AS; Hirano L; Yih J
    Antimicrob Agents Chemother; 1988 Feb; 32(2):231-5. PubMed ID: 3129985
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adaptive resistance of Pseudomonas aeruginosa induced by aminoglycosides and killing kinetics in a rabbit endocarditis model.
    Xiong YQ; Caillon J; Kergueris MF; Drugeon H; Baron D; Potel G; Bayer AS
    Antimicrob Agents Chemother; 1997 Apr; 41(4):823-6. PubMed ID: 9087497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.